A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-b, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC).
SHR-1701
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A phase Ib study of SHR-1701, a bifunctional fusion protein targeting PD-L1 and TGF-b, in patients with recurrent or metastatic nasopharyngeal carcinoma (RM-NPC). ### Output: SHR-1701